2019
Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study
Shah VN, DuBose SN, Li Z, Beck RW, Peters AL, Weinstock RS, Kruger D, Tansey M, Sparling D, Woerner S, Vendrame F, Bergenstal R, Tamborlane WV, Watson SE, Sherr J. Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study. The Journal Of Clinical Endocrinology & Metabolism 2019, 104: 4356-4364. PMID: 31127824, PMCID: PMC7296129, DOI: 10.1210/jc.2018-02763.Peer-Reviewed Original ResearchConceptsContinuous glucose monitoringMedian timeAge groupsProspective studyNondiabetic individualsGlucose levelsAverage glucoseNonobese body mass indexT1D Exchange Clinic NetworkContinuous glucose monitoring (CGM) profilesInsulin-requiring patientsMulticenter prospective studyBody mass indexDifferent age groupsNondiabetic childrenNondiabetic populationGlycemic profileMass indexNondiabetic participantsGlycemic variabilityMean glucoseClinic networkCGM metricsGlycemic metricsGlucose monitoring
2017
Continuous Glucose Monitoring in Very Preterm Infants: A Randomized Controlled Trial
Galderisi A, Facchinetti A, Steil GM, Ortiz-Rubio P, Cavallin F, Tamborlane WV, Baraldi E, Cobelli C, Trevisanuto D. Continuous Glucose Monitoring in Very Preterm Infants: A Randomized Controlled Trial. Pediatrics 2017, 140: e20171162. PMID: 28916591, DOI: 10.1542/peds.2017-1162.Peer-Reviewed Original ResearchConceptsVery preterm infantsGlucose infusion rateContinuous glucose monitoringPreterm infantsCGM groupPercentage of timeEuglycemic rangeSevere hyperglycemiaSevere hypoglycemiaGlycemic variabilityGlucose monitoringCare blood glucose monitoringUse of CGMPoor neurologic outcomeImpaired glucose controlBlood glucose monitoringBlood glucose determinationNeurologic outcomeSecondary outcomesInsulin titrationPrimary outcomeWeeks' gestationControlled TrialsGlucose controlBirth weight
2012
Use of continuous glucose monitoring in children and adolescents *
Phillip M, Danne T, Shalitin S, Buckingham B, Laffel L, Tamborlane W, Battelino T, Participants F. Use of continuous glucose monitoring in children and adolescents *. Pediatric Diabetes 2012, 13: 215-228. PMID: 22284160, DOI: 10.1111/j.1399-5448.2011.00849.x.Peer-Reviewed Original Research
2011
Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline
Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, Wolpert H. Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline. The Journal Of Clinical Endocrinology & Metabolism 2011, 96: 2968-2979. PMID: 21976745, DOI: 10.1210/jc.2010-2756.Peer-Reviewed Original ResearchConceptsReal-time continuous glucose monitoringContinuous glucose monitoringStrength of recommendationsQuality of evidenceEndocrine SocietyPractice guidelinesEndocrine Society Clinical Practice GuidelineGrading of RecommendationsClinical practice guidelinesRisk of hypoglycemiaEvidence-based guidelinesEvidence-based recommendationsTask ForceAdult hospital settingsDiabetes Technology SocietyAdult outpatientsAdolescent outpatientsHospital settingGlucose monitoringEuropean SocietyOutpatientsGuidelinesTarget levelGroup meetingsGlycemia
2010
Statement by the American Association of Clinical Endocrinologists Consensus Panel on Continuous Glucose Monitoring
Blevins TC, Bode BW, Garg SK, Grunberger G, Hirsch IB, Jovanovič L, Nardacci E, Orzeck EA, Roberts VL, Tamborlane WV, Rothermel C. Statement by the American Association of Clinical Endocrinologists Consensus Panel on Continuous Glucose Monitoring. Endocrine Practice 2010, 16: 730-745. PMID: 21356637, DOI: 10.4158/ep.16.5.730.Peer-Reviewed Original Research
2009
A Tale of Two Compartments: Interstitial Versus Blood Glucose Monitoring
Cengiz E, Tamborlane WV. A Tale of Two Compartments: Interstitial Versus Blood Glucose Monitoring. Diabetes Technology & Therapeutics 2009, 11: s-11-s-16. PMID: 19469670, PMCID: PMC2903977, DOI: 10.1089/dia.2009.0002.Peer-Reviewed Original Research
2008
Sensor-augmented pump therapy in type 1 diabetes
Weinzimer SA, Tamborlane WV. Sensor-augmented pump therapy in type 1 diabetes. Current Opinion In Endocrinology Diabetes And Obesity 2008, 15: 118-122. PMID: 18316945, DOI: 10.1097/med.0b013e3282f7960b.Peer-Reviewed Original Research
2006
Fulfilling the promise of insulin pump therapy in childhood diabetes
Tamborlane WV. Fulfilling the promise of insulin pump therapy in childhood diabetes. Pediatric Diabetes 2006, 7: 4-10. PMID: 16774611, DOI: 10.1111/j.1399-543x.2006.00171.x.Peer-Reviewed Original ResearchConceptsContinuous glucose monitoring systemContinuous subcutaneous insulin infusion (CSII) treatmentType 1 diabetes mellitusRapid-acting insulin analoguesTreatment of T1DMComplications TrialDiabetes mellitusDiabetes controlGlucose monitoring systemChildhood diabetesFavorable outcomeInsulin analoguesInfusion treatmentInsulin pumpTherapyMinimal riskT1DMDiabetesInsulinTreatmentMellitusHypoglycemiaCSIIRecent introduction
2005
A Randomized Multicenter Trial Comparing the GlucoWatch Biographer With Standard Glucose Monitoring in Children With Type 1 Diabetes
Chase HP, Beck R, Tamborlane W, Buckingham B, Mauras N, Tsalikian E, Wysocki T, Weinzimer S, Kollman C, Ruedy K, Xing D. A Randomized Multicenter Trial Comparing the GlucoWatch Biographer With Standard Glucose Monitoring in Children With Type 1 Diabetes. Diabetes Care 2005, 28: 1101-1106. PMID: 15855573, DOI: 10.2337/diacare.28.5.1101.Peer-Reviewed Original ResearchConceptsUsual care groupStandard glucose monitoringTimes/weekCare groupGlucose monitoringSevere hypoglycemiaSevere hypoglycemia eventsType 1 diabetesTrial ComparingGlycemic controlHypoglycemia eventsSkin reactionsType 1HypoglycemiaStudy outcomesSkin irritationGlucoWatch G2 BiographerMonthsSensor useWeeksGroupGlucoWatch biographerExcessive alarmsDiabetesMean value